Bone/Mineral Metabolism News

In the year after experiencing a hip fracture, risk for death increases by 33% in men and 20% in women, with this risk continuing to persist for 10 years, according to a hospital-based registry analysis published in The Journal of Clinical Endocrinology & Metabolism.

Amgen and UCB have resubmitted a biologics license application to the FDA for romosozumab for the treatment of osteoporosis in postmenopausal women at high risk for fracture, according to a press release from both companies.

AMSTERDAM — Patients with osteoporosis who experience a fracture are at an immediate increased risk for sustaining another within 2 to 3 years, presenting a “unique window of opportunity” for treatment, according to a presentation at the EULAR Annual Congress. “

Akhila Balasubramanian

Adults prescribed statin therapy after a stroke were less likely to sustain a fracture vs. similar patients not prescribed statin therapy, according to findings from a population-based study conducted in Taiwan.

June is Men’s Health Month, an annual commemoration intended “to heighten the awareness of preventable health problems and encourage early detection and treatment of disease among men and boys,” according to MensHealthMonth.org.

In an update to its 2011 recommendations, the U.S. Preventive Services Task Force recommends screening with bone measurement testing to prevent osteoporotic fractures in women aged at least 65 years and in postmenopausal, high-risk women younger than 65 years.

Older adults experiencing long-term or recent weight loss of at least 5% showed deterioration in both cortical and trabecular bone density and microarchitecture, especially at the weight-bearing skeleton, according to findings published in the Journal of Bone and Mineral Research.

Premenopausal women with hormone receptor-positive early-stage breast cancer randomly assigned zoledronic acid during chemotherapy experienced an increase in bone mineral density over 2 years vs. women assigned placebo, according to findings published in Bone.

Women with type 1 diabetes are nearly three times more likely to develop systemic rheumatic disease vs. men with diabetes, increasing their likelihood of developing other nonrheumatic autoimmune conditions, according to findings published in the Journal of Diabetes and Its Complications.